Whereas VEGF inhibits ASMase, anti-VEGFR2 antibodies de-repress ASMase, enhancing endothelial apoptosis and drug-induced tumor response in ASMase occurs only if anti-angiogenic reagents are provided within 1C2 hours prior to irradiation [5, 6]
Whereas VEGF inhibits ASMase, anti-VEGFR2 antibodies de-repress ASMase, enhancing endothelial apoptosis and drug-induced tumor response in ASMase occurs only if anti-angiogenic reagents are provided within 1C2 hours prior to irradiation [5, 6]. conventional anti-cancer drugs. Anti-angiogenic tumor effects have been extensively explored, conceptualized to either normalize dysfunctional tumor vasculature or to prevent recruitment of circulating endothelial precursors into tumor, aborting hypoxia-driven VEGF-mediated tumor revascularization [7, 8]. These paradigms have dictated the mode of delivery of anti-angiogenic drugs in combination with chemotherapy. Thus, clinical trials invariably have been designed to generate strong anti-angiogenesis irrespective of chemotherapeutic scheduling [9]. Such application protocols do not parallel the time-restricted application of anti-angiogenic drugs necessary for ASMase de-repression. Fzd10 Our data inidcate that synchronized delivery of anti-angiogenic drugs and Finafloxacin Finafloxacin chemotherapy to de-repress ASMase is required to optimally chemosensitize tumor response in pre-clinical models. 2. Materials and Methods 2.1. Endothelial cell cultures Bovine Aortic Endothelial Cells (BAEC) were established from the intima of bovine aorta as described [10]. Stock cultures were grown in 100-mm culture dishes in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with glucose (1 g/liter), 5% heat-inactivated calf serum (CS), penicillin (50 units/ml), and streptomycin (50 g/ml). Purified human recombinant fibroblast growth factor (bFGF) (1 ng/ml; R&D Systems, Inc., Minneapolis, MN) was added every other day during the phase of exponential growth. After 8C10 days in culture, cells reach confluence and exhibit features of contact-inhibited monolayers. These plateau phase cells were either used for experiments, or further sub-cultured (up to a maximum of 10 times) at a split ratio of 1 1:8. For sub-culturing, monolayers were dissociated with STV (0.05% trypsin and 0.02% EDTA in PBS) for 2C3 min at 22C, washed twice in 5% CS-DMEM, and resuspended in DMEM with supplements as above. These mild conditions of trypsinization were sufficient to detach cells but not injure, stimulate, or affect cell functions in a detectable way. Cultures of BAEC were maintained at 37C in 10% CO2 humidified incubators. Human coronary artery endothelial cells (HCAEC) were obtained from Clonetics? Coronary Artery Endothelial Cell Systems (Cambrex Bio Science Inc.). For culturing and sub-culturing of HCAEC, Clonetics cell system components were used: EBM?-2, Endothelial cell Basal Medium-2 with addition of Clonetics EGM-2-MV SingleQuots containing growth supplements (Cambrex) and 50 mg/ml endothelial mitogen (ECGF) (Biomedical Technologies, Inc.). For sub-culturing, monolayers were dissociated with Clonetics? Trypsin/EDTA solution for 2C3 min at 22C at a split ratio of 1 1:4 to expand the cell population for experiments. HCAEC cultures were maintained at 37C in 5% CO2 humidified incubators. 2.2. Apoptosis (In Vitro) Apoptosis was assessed by examining morphologic changes in nuclear chromatin. Cells were fixed with 2% paraformaldehyde, washed with PBS and stained with 100 ml of 24 g/ml ceramide quantification, blood samples were collected from mice at different time points following treatment. Serum was immediately extracted from blood samples by centrifugation and shipped overnight on dry ice to the Lipidomics Shared Resource Facility (Medical University of South Carolina, Charleston, SC, USA) for mass spectrometry (MS) analysis. After extraction, sphingolipids were separated by high performance liquid chromatography, introduced to the electrospray ionization source and then analyzed by double MS using TSQ Finafloxacin 7000 triple quadrupole mass spectrometer (Thermo-Fisher Scientific) as described previously [12]. 2.4. ASMase Activity Assay ASMase Activity was quantified using a radioenzymatic assay with [14C-methylcholine] sphingomyelin (Perkin Elmer)[13]. Cell lysates or mice serum samples were incubated with [14C-methylcholine]-sphingomyelin substrate (0.026 mCi/9.5 nmol) in 250 mM sodium acetate, pH 5.0 supplemented with 0.1% Triton X-100 and 1 mM EDTA or 0.1 mM ZnCl. Reactions were terminated after 1 hour with CHCl3:MeOH:1N HCl (100:100:1, v/v/v), and product within the aqueous following Folch extraction was quantified by a Beckman Packard 2200 CA Tricarb scintillation counter. 2.5. CRM detection by confocal microscopy BAEC were grown on CC2-treated chamber slides (Nalgene, Nunc International Corp., Naperville, USA) and then exposed to etoposide or paclitaxel with or without pre-incubation with nystatin (30 g/ml, Sigma) for 30 min. BAEC were then washed in cold PBS, fixed for 15 min in fresh-made 2% paraformaldehyde, Finafloxacin washed 2 with cold PBS, and blocked with 5% FBS in PBS for 20 min at room temperature. Cells were stained with primary Ab to ceramide, MID 15B4 IgM (1:50 dilution) (Alexis Biochemicals Corporation) for 1 hour at room temperature, washed 3 in PBS, and stained with Texas Red-conjugated secondary antibody (Jackson Immunoresearch Laboratories, Inc.) at 1:500 dilution for 1 hour at room temperature. Nonspecific fluorescence was excluded using isotope control IgM (BD Biosciences). Cells were washed 3, stained with DAPI and mounted in 0.1% paraphenylenediamine. Fluorescence was detected using.